J J Pocidalo - Concepedia

Author

J J Pocidalo

Also Known As

J J POCIDALO, J J Pocidalo, J. J. Pocidalo, J.-J. Pocidalo, J.J Pocidalo, J.J. Pocidalo, Jean-Jacques Pocidalo, Jean‐Jacques Pocidalo, Jean‐Jacques Pocidalo PhD

108

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Hôpital Bichat-Claude-Bernard Université Claude Bernard Lyon 1 Inserm Institut de Médecine et d'Epidémiologie Africaines Hôpital Saint-Louis

About

J J Pocidalo is an author at Hôpital Bichat-Claude-Bernard specializing in medicine, drug resistance, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	37	1.2K
2	Health Sciences	14	17	588
3	Engineering	1	1	14
4	Public Health	1	1	12
5	Social Sciences	1	1	15

J J Pocidalo

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem Marie‐Laure Joly‐Guillou, Michel Wolff, J J Pocidalo, Antimicrobial Agents and Chemotherapy Acute Lung InjuryExperimental Mouse ModelLung InflammationVitro PaeDrug Resistance	1997	103
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages Christian Perronne, Achilleas Gikas, C. Truffot-Pernot, Antimicrobial Agents and Chemotherapy ImmunologyAntimicrobial ChemotherapyMycobacterium Avium ComplexDrug ResistanceMedical Microbiology	1990	81
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages C. Perronne, Achilleas Gikas, C. Truffot-Pernot, Antimicrobial Agents and Chemotherapy ImmunologyAntimicrobial ChemotherapyMycobacterium Avium ComplexDrug ResistanceM. Avium Complex	1991	81
Tissue acid‐base balance and oxygen metabolism in human cerebral infarction studied with positron emission tomography A. Syrota, Madeleine Castaing, D Rougemont, Annals of Neurology	1983	63
Antipneumococcal Activity of Ciprofloxacin, Ofloxacin, and Temafloxacin in an Experimental Mouse Pneumonia Model at Various Stages of the Disease E. Azoulay-Dupuis, J.P. Bédos, E Vallée, The Journal of Infectious Diseases	1991	61
In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice Christophe Piketty, Francis Derouin, B Rouveix, Antimicrobial Agents and Chemotherapy Parasitic DiseaseParasitic LoadsAntibioticsAntiparasitic AgentMedicine	1990	54
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis Francis Derouin, R Almadany, F. Chau, Antimicrobial Agents and Chemotherapy Parasite BurdenSynergistic ActivityParasitic DiseaseAcute Experimental ToxoplasmosisAntibiotics	1992	53
Macrolides and immunity: effects of erythromycin and spiramycin on human mononoclear cell proliferation Yvon Roche, Marie‐Anne Gougerot‐Pocidalo, Michèle Fay, Journal of Antimicrobial Chemotherapy ImmunologyCell DeathCellular PharmacologyCell CycleAntimicrobial Chemotherapy	1986	53
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia E. Azoulay-Dupuis, E Vallée, Benoît Veber, Antimicrobial Agents and Chemotherapy Anti-infective AgentsStreptococcus PneumoniaeSubcutaneous InjectionsAntibioticsHealth Sciences	1992	53
Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia E. Azoulay-Dupuis, E Vallée, J.P. Bédos, Antimicrobial Agents and Chemotherapy Azithromycin AccountAntimicrobial SusceptibilityTherapeutic ActivitiesAntibioticsExtended Half-life	1991	51

Page 1